“PROVITAL” combines the clinical assessment of patients using an addictions neuroclinical assessment (ANA) as an intake battery combining an electronic wearable and digital research monitoring about changes in behavior and drinking to guide treatments for those that are at high risk of relapse, and to deliver specific or additional interventions at the time that they are needed most.
The study is comprised of an eligibility screening activity, a baseline set of measurements, followed by a monthly collection of an electronic wearable and 3-times daily pseudo-randomized EMAs, and weekly follow-ups for 12 weeks.
The study is a longitudinal detailed app-based assessments of impulsivity, craving, drinking, life stressors, in various social contexts. It includes: